Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes
Clinical trial NCT02081599 · COMPLETED
Trial details
- NCT number
- NCT02081599
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-01-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.